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Hyaluronic acid gel improves
pregnancy outcomes after
repeated dilatation
and curettage
The Post Abortion Prevention of Adhesions (PAPA) study, a
multicenter prospective randomized controlled trial (RCT)
from a Dutch team, studied the effect of application of auto-
crosslinked hyaluronic acid (ACP) gel for intrauterine adhe-
sions (IUAs) after dilatation and curettage (D&C) for miscar-
riage in women who have experienced at least one previous
D&C (1). The ACP gel (obtained from hyaluronic acid conden-
sation), is a resorbable gel administrated into the uterine cavity
after D&C in an attempt to reduce IUAs. In the first part of the
study, all patients had a follow-up hysteroscopy 8–12 weeks
after D&C when the IUAs were evaluated according to the
two most accepted classifications by the American Fertility
Society and the European Society of Gynecological Endos-
copy. The rate of IUAs differed between the groups, as follows:
13%among the intervention group and 30.6%among the con-
trol group. The ACP gel reduced the rate of IUAswith a relative
risk (RR) of 0.43. Furthermore, in the intervention group the
rate of moderate-to-severe IUAs was lower than in the control
group. In addition, adhesiolysis was more often performed in
the follow-up hysteroscopy among control patients, which
might have diluted differences between the cases and the con-
trols regarding pregnancy and fertility outcomes, as reported
in a subsequent article by the study group (2).
The relationship between IUAs and adverse reproductive
outcomes is well known. The IUAs may predispose women
to infertility and recurrent miscarriages. Trauma is the major
cause of IUAs and individual factors, such as age, race, nutri-
tional status, and infectious disease processes, also influence
adhesion formation (3). According to a systematic review (3)
IUA prevention includes good surgical technique, an early
therapeutic second-look hysteroscopy, and barrier methods
(such as ACP gel). The role of hormonal or antibiotic treat-
ments remains unknown.
In addition to affecting reproduction, IUAs may cause
menstrual abnormalities, dysmenorrhea, and pelvic pain.
The IUAs may also obstruct the cervix, which may lead to
hematometra, pain, and difficulties in obtaining endometrial
samples or in entering the uterine cavity at hysteroscopy.
However, clinical reproductive outcomes, such as a lower
miscarriage rate, a shorter time to conception, and an
improved live birth rate, are most important for the patient.
In the third part of the Dutch study, questionnaires were
sent to patients 30 months after randomization. These
included questions about menstruation, contraception, and
pregnancies. Women in the control group tried to conceive
more often and they actually did (77.6% vs. 92.2%). However,
significantly more ongoing pregnancies (74.6% vs. 67.2%)
were detected among the intervention group and this differ-
ence increased further when adjusted for age (2). Median
time to conception leading to live birth was shorter (21.9 vs
36.1months). Also,miscarriage ratewas lower in the interven-
tion group. The live birth rate, ectopic pregnancy, and termi-VOL. 114 NO. 3 / SEPTEMBER 2020nation of pregnancy rates were similar. Although the study
was not powered to evaluate reproductive outcomes, the find-
ings are important, demonstrating that ACP gel improves
pregnancy outcomes among women with repeated D&Cs.
A recent meta-analysis (4) evaluated the efficacy of hyal-
uronic acid gel in preventing IUAs after different uterine op-
erations. Researchers found seven RCTs including the
aforementioned Dutch studies with a total of 952 patients.
The use of hyaluronic acid gel reduced the incidence and
the severity of IUAs by almost 60% (RR 0.42, 95% confidence
interval 0.30–0.57) regardless of the type of surgery per-
formed (hysteroscopy or D&C). In addition, hyaluronic acid
gel improved the pregnancy rates after intrauterine opera-
tions (RR 1.94, 95% confidence interval 1.46–2.60). However,
the investigators concluded that follow-up data in these
studies were insufficient to evaluate the effect on postopera-
tive pregnancy or live birth rate. Therefore, it is very impor-
tant that the 42-month results of the PAPA study are
published at present. I congratulate the investigators for their
invaluable work. Preforming such a high-quality RCT requires
a lot of work. The methodology in the study was meticulous
and the drop-out rate is extremely low.
High-quality RCTs to assess the effectiveness of antiadhe-
sion agents are still needed before these strategies may be
strongly recommended for routine use to improve pregnancy
outcomes in women undergoing intrauterine operations (4).
In the meantime, healthcare providers should carefully eval-
uate available data of these agents and determine whether
to support their routine, prophylactic use. We can already
conclude that ACP gel should be offered to women undergo-
ing repeated D&C. The Dutch collaboration should encourage
other countries to build similar consortiums that effectively
build RCT studies.
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